Zacks Industry Outlook Highlights Aflac, Unum, Globe Life, Trupanion and Employers
📈 The Zacks Accident and Health Insurance industry is expected to benefit from increased underwriting exposure and demand for group insurance.
⚠️ Higher inflation, rising medical costs, and soft pricing over recent quarters could offset some of the industry's positive drivers.
💰 The $300 billion A&H insurance market in 2024 is projected to expand to approximately $420 billion by 2033.
📉 Pricing pressure is expected to continue due to inflation, demographic changes, and efforts to retain market share.
🤖 Accelerated adoption of AI, data analytics, and telemedicine is helping insurers gain a competitive edge and reduce claim expenses.
🏆 The Zacks Accident and Health Insurance industry currently holds a Rank #102, placing it in the top 42% of all Zacks industries.
📊 The industry has outperformed its Finance sector year-to-date with a 5.5% gain against the sector's 0.9% decline.
💵 Aflac (AFL) is expected to benefit from strategic growth investments and the Argus buyout, though 2026 earnings estimates show a slight decrease.
📈 Unum Group (UNM) expects adjusted operating income per share between $8.60 and $8.90 for 2026 with premium growth of 4-7%.
🐾 Trupanion (TRUP), a pet insurer, delivered a trailing four-quarter earnings surprise of 250% on average with strong long-term growth potential.
🏭 Globe Life (GL) is driven by positive revenue trends in its Life and Health Insurance segments, particularly from Liberty National.
🛡️ Employers Holdings (EIG), the 19th largest workers' compensation provider, expects a significant 139.8% increase in 2026 earnings estimates.
📉 The industry trades at a trailing 12-month price-to-book ratio of 1.68X, significantly lower than the S&P 500 composite's 8.08X.
🔮 Analyst confidence is gradually increasing as aggregate earnings estimate revisions show positive growth potential for constituent companies.
- The Accident and Health Insurance industry is projected to expand from $300 billion in 2024 to approximately $420 billion by 2033, reflecting strong long-term growth potential.
- Aflac delivered a trailing four-quarter earnings surprise of 7.86% on average, demonstrating robust performance ahead of expectations.
- Unum Group expects adjusted operating income per share between $8.60 and $8.90 for 2026, with premium growth anticipated in the 4-7% band driven by persistence and new sales.
- Trupanion delivered a trailing four-quarter earnings surprise of 250% on average and holds a Growth Score of A, indicating strong upside potential.
- Employers Holdings consensus estimates suggest a significant 139.8% year-over-year increase in earnings for 2026, followed by a 5.6% increase in 2027.
- Globe Life's Liberty National division is expected to drive top-line growth with net life and health sales projected to grow in the mid-teens.
- The industry benefits from increasing adoption of technology, including AI which could reduce workers' compensation claim expenses by about 45%.
- Unum Group has an impressive dividend track record, having increased dividends 17 times in the last 16 years with an estimated 10-15% increase going forward.
- The Zacks Consensus Estimate for Aflac's 2026 earnings implies a year-over-year decrease of 4.9%, indicating near-term earnings contraction.
- The consensus estimate for Aflac's 2026 earnings has moved south in the past 30 days, reflecting deteriorating analyst sentiment.
- Higher inflation and rising medical costs are expected to offset industry positives, creating headwinds for profitability.
- Soft pricing is anticipated to persist over the coming quarters, which could constrain premium growth and margins.
- Efforts to retain market share will further increase pricing pressure, which might curb top-line growth.
- The industry currently trades at a price-to-book ratio of 1.68X, significantly below the S&P 500 composite's 8.08X and the sector's 4.28X, suggesting potential undervaluation or market skepticism.
- Over the past five years, the industry has traded as low as 0.97X, indicating significant volatility and downside risk in valuation multiples.